Home/Filings/4/0001415889-24-016101
4//SEC Filing

Yu Yong 4

Accession 0001415889-24-016101

CIK 0001231457other

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 9:40 PM ET

Size

7.6 KB

Accession

0001415889-24-016101

Insider Transaction Report

Form 4
Period: 2024-05-29
Yu Yong
VP, Clinical Trial Operations
Transactions
  • Purchase

    Common Stock

    2024-05-29+2,5002,500 total
  • Purchase

    Common Stock Warrant (Right to Buy)

    2024-05-29+2,5002,500 total
    Exercise: $5.25From: 2024-05-29Exp: 2029-05-29Common Stock (2,500 underlying)
Footnotes (2)
  • [F1]The Reporting Person's purchase reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of common stock on December 15, 2023. The Reporting Person has agreed to pay to the Issuer the profit realized in connection with the short-swing transaction, less transaction costs.
  • [F2]The reported securities consist of shares of common stock sold together with accompanying warrants to purchase common stock. The combined price of each share of common stock offered together with one warrant was $4.00.

Issuer

GENELUX Corp

CIK 0001231457

Entity typeother

Related Parties

1
  • filerCIK 0001937482

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 9:40 PM ET
Size
7.6 KB